Who should pay for million-dollar gene therapies? – Times of Malta
Times of Malta |
Who should pay for million-dollar gene therapies?
Times of Malta If you were born with a rare form of blindness, there is now a treatment for you that may restore your eyesight. That’s because gene therapies became a clinical reality in 2017. Yet many people with rare diseases that could be treated in this way may … |
PMLiVE |
Takeda’s Alofisel becomes Europe’s first allogenic stem cell therapy
PMLiVE Takeda has chalked up a big win this week after receiving a European licence for Alofisel (darvadstrocel), marking the first approved allogenic stem cell therapy set to hit the EU market. Alofisel – previously Cx601 – is approved to treat complex … |
The Scientist |
Stem Cell Therapy for Crohn’s Disease Approved in Europe
Labiotech.eu (blog) Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved Alofisel (darvadstrocel), a stem cell therapy to treat complex perianal … Texas Stem Cell Law Opens Door for Controversial TreatmentsThe Scientist MS stem cell treatment stabilises disease and reduced disability …Medical Xpress Takeda’s off-the-shelf stem cell therapy approved in EuropeBioPharma-Reporter.com PMLiVE –Villages-News –BioNews all 16 news articles » |